SynBioBeta Speaker
Da Lin
General Biotechnologies
Principal Scientist
Dr Da Lin is the Principal Scientist at General Biotechnologies where he leads the Molecular Biology team building a pipeline of oral GLP-1 peptides delivered inside cyanobacterial cells. Da has a PhD from the University of Oxford, is a former postdoctoral Immunologist and a two-time founder of SynBio spinouts in the field of DNA assembly technology and Epigenetics.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Da
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
